Kasai K, Suzuki H, Kikuchi T, Ieiri T, Takemura Y
Endocrinol Jpn. 1976 Aug;23(4):347-54.
In order to compare the acute effects of three kinds of antithyroid agents of iodide (I-), propylthiouracil (PTU) and PTU combined with iodide (PTU+I-) on thyroid function in hyperthyroid patients with diffuse goiter, serum concentrations of thyroxine (T4), triiodothyronine (T3), T3-resin sponge uptake (T3-RU) and free thyroxine index (FT4I) were employed as thyroid function parameters. In the group given iodine (1 mg/day) as iodinated-lecithine, the initial values of T4, T3, T3-RU and FT4I were 20.9 +/- 1.6 microng/100 ml (T4), greater than 740 ng/100 ml (T3), 49.5 +/- 2.3% (T3-RU) and 14.7 +/- 1.8 (FT4I). At the end of one week of therapy, they decreased clearly to 15.6 +/- 2.2 microng/100 ml, 457 +/- 87 ng/100 ml, 42.2 +/- 4.0% and 9.7 +/- 2.4. The so-called "escape phenomenon" from iodide inhibition was observed in serum T4, T3-RU and FT4I values at the end of two weeks of iodide therapy, while serum T3 continued to decrease but the value of T3 was far outside of the normal range. In the PTU group (300 mg/day), thyroid function parameters were 22.5 +/- 0.8 microng/100 ml (T4), greater than 592 ng/100 ml (T3), 54.9 +/- 1.0% (T3-RU) and 18.7 +/- 1.0 (FT4I) before treatment. They decreased continually week by week. At the end of four-week treatment with PTU, the value of each thyroid function parameter was 11.1 +/- 1.9 microng/100 ml, 229 +/- 56 ng/100 ml, 36.6 +/- 4.4% and 5.7 +/- 1.7. In the group of hyperthyroidism simultaneously given both PTU and iodide (300 mg/PTU and 1 mg/iodine), these thyroid function parameters decreased as well as in the group treated with PTU alone for more than two weeks. More rapid or significant decrease of T4, T3, T3-RU and ft4i in PTU+I- group than in PTU group was observed in the present study. These results suggested strongly that iodide alone was not an adequate therapy for hyperthyroidism as well known and they were also compatible with the idea that the concomitant administration of PTU and iodide was more effective in the early phase of therapy of hyperthyroidism than PTU alone.
为比较碘化物(I-)、丙硫氧嘧啶(PTU)及丙硫氧嘧啶联合碘化物(PTU+I-)这三种抗甲状腺药物对弥漫性甲状腺肿甲亢患者甲状腺功能的急性影响,采用血清甲状腺素(T4)、三碘甲状腺原氨酸(T3)、T3树脂摄取率(T3-RU)及游离甲状腺素指数(FT4I)作为甲状腺功能参数。在给予碘化卵磷脂形式的碘(1毫克/天)的组中,T4、T3、T3-RU及FT4I的初始值分别为20.9±1.6微克/100毫升(T4)、大于740纳克/100毫升(T3)、49.5±2.3%(T3-RU)及14.7±1.8(FT4I)。治疗一周结束时,它们明显降至15.6±2.2微克/100毫升、457±87纳克/100毫升、42.2±4.0%及9.7±2.4。碘治疗两周结束时,血清T4、T3-RU及FT4I值出现了所谓的碘抑制“逃逸现象”,而血清T3持续下降但仍远超出正常范围。在PTU组(300毫克/天)中,治疗前甲状腺功能参数为22.5±0.8微克/100毫升(T4)、大于592纳克/100毫升(T3)、54.9±1.0%(T3-RU)及18.7±1.0(FT4I)。它们逐周持续下降。PTU治疗四周结束时,各甲状腺功能参数值分别为11.1±1.9微克/100毫升、229±56纳克/100毫升、36.6±4.4%及5.7±1.7。在同时给予PTU和碘化物(300毫克PTU和1毫克碘)的甲亢组中,这些甲状腺功能参数与单独使用PTU治疗两周以上的组一样下降。本研究观察到PTU+I-组中T4、T3、T3-RU及FT4I的下降比PTU组更快或更显著。这些结果有力地表明,众所周知,单独使用碘化物并非治疗甲亢的充分疗法,同时也与以下观点相符,即在甲亢治疗早期,PTU与碘化物联合使用比单独使用PTU更有效。